EastGate Pharmaceutical Token (EGP)
OngoingJun 01, 2023 – Jul 31, 2023
EastGate Pharmaceutical Token (EGP). Creating solutions to vital pharmaceutical problems by merging pharmacy with blockchain. EGP Token would be used to make payments in pharmaceutical stores across the world.
IMPORTANT: By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice.
What is EastGate Pharmaceutical Token
EastGate Biotech Corp. is a dynamic biotech company concentrating on altering the delivery ways for well-known drugs, currently administered only by injections, to non-invasive (oral or sublingual) routes. We are developing a technology platform for enhanced drug delivery designed to provide alternative administration of known drugs with the goal of offering patient-friendly products to improve compliance and increase health benefits to fit today's health-conscious lifestyles. At the present time our technology focuses on the delivery of insulin via a liquid insulin mouth solution based on proprietary composition, but we believe that our technology may also be applicable to the delivery of other active pharmaceutical ingredients. We may also develop other novel formulations of pharmaceutical and natural products. The company has identified several biologically active existing molecules that address unmet needs of patients, especially those with ever-growing chronic conditions.
The company will focus on validating its delivery technology platform and determining different applications for expanding therapeutic treatments. The company intends to out-license different applications. We have not entered into any definitive agreements with respect to the foregoing and there is no guarantee that the Company will enter into such agreements on favorable terms or at all.
Our secondary goal is to leverage our technology for the oral delivery of other active pharmaceutical ingredients for the treatment of non-diabetes indications. If we are successful in obtaining regulatory approval, we may also out-license our intellectual property to other pharmaceutical companies.
DetailsPre-sales: Apr 01, 2023 - May 31, 2023
Public sales: Jun 01, 2023 - Jul 31, 2023
Token supply: 100,000,000,000 EGP
Total tokens for sale: 50,000,000,000 EGP
Soft cap: 150,000 USD
Hard cap: 10,000,000 USD
LegalBlockchain Platform: Ethereum
Token infoTicker: EGP
Token standard: ERC-20
Token price in USD: 1 EGP = 0.01 USD
Accepted currencies: BTC, ETH, USDT, TRX, DOGE
Token Sale Program - 60%
Reserve Fund - 8%
Team and Founders - 15%
Board Advisors - 4%
Ecosystem Development - 7%
Marketing and Bounty - 6%
Engineering and Development - 40%
Business Development - 12%
Marketing & Promotion - 20%
Legal & Regulation - 10%
Operational & Administration - 8%
Contingency - 4%
Partners - 6%
EastGate Pharmaceutical Token Roadmap
Start of the ERC20 Crypto Platform Development
Start of the Preparation for the ERC20 Token Testing
Deployed Our ERC20 Token (EGP) Over Main Network
Listing on 2 CEX platforms
Collaboration with top pharmaceutical stores across the world to accept EGP token as payment in stores for pharmaceutical services and items
Training of 10,000 pharmacists to make positive impact in the health field
Launch of EastGate blockchain